RGNX•benzinga•
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer
Summary
RegenXBio's RGX-202 gene therapy improved function in Duchenne patients at 9 and 12 months, supporting a 2026 BLA filing and 2027 launch.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 5, 2025 by benzinga